Christina Decatur
Christina Decatur
Dirección de correo verificada de
Citado por
Citado por
PRAME as an independent biomarker for metastasis in uveal melanoma
MG Field, CL Decatur, S Kurtenbach, G Gezgin, PA Van Der Velden, ...
Clinical cancer research 22 (5), 1234-1242, 2016
Driver mutations in uveal melanoma: associations with gene expression profile and patient outcomes
CL Decatur, E Ong, N Garg, H Anbunathan, AM Bowcock, MG Field, ...
JAMA ophthalmology 134 (7), 728-733, 2016
Single-cell analysis reveals new evolutionary complexity in uveal melanoma
MA Durante, DA Rodriguez, S Kurtenbach, JN Kuznetsov, MI Sanchez, ...
Nature communications 11 (1), 1-10, 2020
L-DOPA Is an Endogenous Ligand for OA1
VM Lopez, CL Decatur, WD Stamer, RM Lynch, BS McKay
PLoS biology 6 (9), e236, 2008
Punctuated evolution of canonical genomic aberrations in uveal melanoma
MG Field, MA Durante, H Anbunathan, LZ Cai, CL Decatur, AM Bowcock, ...
Nature communications 9 (1), 1-10, 2018
Epigenetic reprogramming and aberrant expression of PRAME are associated with increased metastatic risk in Class 1 and Class 2 uveal melanomas
MG Field, MA Durante, CL Decatur, B Tarlan, KM Oelschlager, JF Stone, ...
Oncotarget 7 (37), 59209, 2016
Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis
LL Cavalcante, ML Cavalcante, TG Murray, MM Vigoda, Y Piña, ...
Clinical ophthalmology (Auckland, NZ) 4, 519, 2010
H Field, MA Durante, CL Decatur, B Tarlan, KM Oelschlager, JF Stone
Science without Numbers, 1980
BAP1 loss is associated with DNA methylomic repatterning in highly aggressive class 2 uveal melanomas
MG Field, JN Kuznetsov, PL Bussies, LZ Cai, KA Alawa, CL Decatur, ...
Clinical cancer research 25 (18), 5663-5673, 2019
2-Deoxy-Glucose Downregulates Endothelial AKT and ERK via Interference with N-Linked Glycosylation, Induction of Endoplasmic Reticulum Stress, and GSK3β ActivationInhibition of …
K Kovács, C Decatur, M Toro, DG Pham, H Liu, Y Jing, TG Murray, ...
Molecular cancer therapeutics 15 (2), 264-275, 2016
Gene expression profiling and PRAME status versus tumor-node-metastasis staging for prognostication in uveal melanoma
L Cai, M Paez-Escamilla, SD Walter, B Tarlan, CL Decatur, BM Perez, ...
American journal of ophthalmology 195, 154-160, 2018
Intravitreal bevacizumab combined with plaque brachytherapy reduces melanoma tumor volume and enhances resolution of exudative detachment
SK Houston, NV Shah, C Decatur, M Lonngi, W Feuer, AM Markoe, ...
Clinical ophthalmology (Auckland, NZ) 7, 193, 2013
Intravitreal and subconjunctival melphalan for retinoblastoma in transgenic mice
NV Shah, DG Pham, TG Murray, C Decatur, E Hernandez, NN Shah, ...
Journal of Ophthalmology 2014, 2014
Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FG), to target the chemoresistant hypoxic regions in LHBETATAG retinal tumors
Y Pina, C Decatur, TG Murray, SK Houston, M Lopez-Cavalcante, ...
Investigative ophthalmology & visual science 53 (2), 996-1002, 2012
Advanced retinoblastoma treatment: targeting hypoxia by inhibition of the mammalian target of rapamycin (mTOR) in LHBetaTag retinal tumors
Y Piña, C Decatur, TG Murray, SK Houston, D Gologorsky, M Cavalcante, ...
Clinical Ophthalmology (Auckland, NZ) 5, 337, 2011
Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-D-glucose on molecular genomics expression in LHBETATAG retinal tumors
Y Piña, SK Houston, TG Murray, T Koru-Sengul, C Decatur, WK Scott, ...
Clinical ophthalmology (Auckland, NZ) 6, 817, 2012
Microincisional vitrectomy for retinal detachment in I-125 brachytherapy-treated patients with posterior uveal malignant melanoma
M Lonngi, SK Houston, TG Murray, RA Sisk, CL Decatur, M Cavalcante, ...
Clinical Ophthalmology (Auckland, NZ) 7, 427, 2013
Genomic evolution of uveal melanoma arising in ocular melanocytosis
MA Durante, MG Field, MI Sanchez, KR Covington, CL Decatur, ...
Molecular Case Studies 5 (4), a004051, 2019
Intraocular metastasis in unilateral multifocal uveal melanoma without melanocytosis or germline BAP1 mutations
MA Durante, SD Walter, M Paez-Escamilla, J Tokarev, CL Decatur, ...
JAMA ophthalmology 137 (12), 1434-1439, 2019
Combined glycolytic inhibition and anti-vascular treatment in retinoblastoma: Novel strategy for tumor control avoids chemotherapy
TG Murray, S Houston, C Decatur, Y Pina, T Lampidis
Cancer Research 72 (8_Supplement), 4642-4642, 2012
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20